Cargando…
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation
Limited epidemiological evidence suggests that the etiology of hormone receptor positive (HR+) breast cancer may differ by levels of histologic grade and proliferation. We pooled risk factor and pathology data on 5,905 HR+ breast cancer cases and 26,281 controls from 11 epidemiological studies. Prol...
Autores principales: | Abubakar, Mustapha, Chang‐Claude, Jenny, Ali, H. Raza, Chatterjee, Nilanjan, Coulson, Penny, Daley, Frances, Blows, Fiona, Benitez, Javier, Milne, Roger L., Brenner, Hermann, Stegmaier, Christa, Mannermaa, Arto, Rudolph, Anja, Sinn, Peter, Couch, Fergus J., Devilee, Peter, Tollenaar, Rob A.E.M., Seynaeve, Caroline, Figueroa, Jonine, Lissowska, Jolanta, Hewitt, Stephen, Hooning, Maartje J., Hollestelle, Antoinette, Foekens, Renée, Koppert, Linetta B., Investigators, kConFab, Bolla, Manjeet K., Wang, Qin, Jones, Michael E., Schoemaker, Minouk J., Keeman, Renske, Easton, Douglas F., Swerdlow, Anthony J., Sherman, Mark E., Schmidt, Marjanka K., Pharoah, Paul D., Garcia‐Closas, Montserrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041155/ https://www.ncbi.nlm.nih.gov/pubmed/29492969 http://dx.doi.org/10.1002/ijc.31352 |
Ejemplares similares
-
High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
por: Abubakar, Mustapha, et al.
Publicado: (2016) -
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups
por: Abubakar, Mustapha, et al.
Publicado: (2016) -
Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas
por: Deb, Siddhartha, et al.
Publicado: (2012) -
Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
por: Drooger, Jan C., et al.
Publicado: (2015) -
Use of DNA–Damaging Agents and RNA Pooling to Assess Expression Profiles Associated with BRCA1 and BRCA2 Mutation Status in Familial Breast Cancer Patients
por: Walker, Logan C., et al.
Publicado: (2010)